C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 957-964

Bentham Science Publishers

Access to resources Recommend Favorite

Elicitation of Dopaminergic Features of Parkinson's Disease in C. elegans by Monocrotophos, an Organophosphorous Insecticide

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 993-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Environmental Toxicants as Extrinsic Epigenetic Factors for Parkinsonism: Studies Employing Transgenic C. elegans Model

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 976-983

Bentham Science Publishers

Access to resources Recommend Favorite

Host Stress and Virulence Expression in Intestinal Pathogens: Development of Therapeutic Strategies Using Mice and C. elegans

By  

Current Pharmaceutical Design, Vol. 17, Iss. 13, 2011-05 ,pp. : 1254-1260

Bentham Science Publishers

Access to resources Recommend Favorite

Mutant genes responsible for Parkinson's disease

By Le W.   Appel S.H.  

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 79-84

Elsevier

Access to resources Recommend Favorite